{"id":"https://openalex.org/W1955656308","doi":"https://doi.org/10.1200/jco.2015.33.7_suppl.423","title":"High dose (HD) IL-2 for metastatic renal cell carcinoma (mRCC) in the targeted therapy era: Extension of OS benefits beyond complete response (CR) and partial response (PR).","display_name":"High dose (HD) IL-2 for metastatic renal cell carcinoma (mRCC) in the targeted therapy era: Extension of OS benefits beyond complete response (CR) and partial response (PR).","publication_year":2015,"publication_date":"2015-03-01","ids":{"openalex":"https://openalex.org/W1955656308","doi":"https://doi.org/10.1200/jco.2015.33.7_suppl.423","mag":"1955656308"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.7_suppl.423","doi":"https://doi.org/10.1200/jco.2015.33.7_suppl.423","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.7_suppl.423","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110201012","display_name":"Sandra Aung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094228","display_name":"Prometheus Biosciences (United States)","ror":"https://ror.org/00jkh1375","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra Aung","raw_affiliation_strings":["Prometheus Laboratory, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Laboratory, San Diego, CA","institution_ids":["https://openalex.org/I4210094228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074731037","display_name":"Michael Andrew Morse","orcid":"https://orcid.org/0000-0002-5725-4533","observed_orcids":["https://orcid.org/0000-0002-5725-4533"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael A. Morse","raw_affiliation_strings":["Duke University Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036199580","display_name":"Michael K.K. Wong","orcid":"https://orcid.org/0000-0002-4247-738X","observed_orcids":["https://orcid.org/0000-0002-4247-738X"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael K.K. Wong","raw_affiliation_strings":["University of Southern California, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California, Los Angeles, CA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090739964","display_name":"Howard L. Kaufman","orcid":"https://orcid.org/0000-0003-1131-004X","observed_orcids":["https://orcid.org/0000-0003-1131-004X","https://orcid.org/0000-0003-3538-4166"]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Kaufman","raw_affiliation_strings":["Rush University Medical Center, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rush University Medical Center, Chicago, IL","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029783882","display_name":"Gregory A. Daniels","orcid":"https://orcid.org/0000-0001-9087-8009","observed_orcids":["https://orcid.org/0000-0001-9087-8009"]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory A. Daniels","raw_affiliation_strings":["UC San Diego Moores Cancer Center, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UC San Diego Moores Cancer Center, La Jolla, CA","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007052233","display_name":"David F. McDermott","orcid":"https://orcid.org/0000-0002-2675-5095","observed_orcids":["https://orcid.org/0000-0002-2675-5095","https://orcid.org/0000-0001-6978-0867"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David F. McDermott","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"7_suppl","first_page":"423","last_page":"423"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-dose-interleukin-2","display_name":"high-dose interleukin-2","score":0.9810000061988831},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9319999814033508},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5479999780654907},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6389999985694885},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.7059999704360962},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6629999876022339},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.7049999833106995},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.7250000238418579},{"id":"https://openalex.org/keywords/il-2-toxicity","display_name":"IL-2 toxicity","score":0.7350000143051147},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.36000001430511475},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.515999972820282},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5630000233650208},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.4580000042915344},{"id":"https://openalex.org/keywords/prognostic-score-2","display_name":"prognostic score 2","score":0.3100000023841858},{"id":"https://openalex.org/keywords/prognostic-score-3","display_name":"prognostic score 3","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9272862672805786},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.539105236530304},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5332806706428528},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5271584391593933},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.49313753843307495},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.46828100085258484},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3908853828907013},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2730603516101837}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.7_suppl.423","doi":"https://doi.org/10.1200/jco.2015.33.7_suppl.423","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.7_suppl.423","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5400000214576721}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2597925678","https://openalex.org/W2511356579","https://openalex.org/W2591304702","https://openalex.org/W2891651484","https://openalex.org/W2891241962","https://openalex.org/W2929554293","https://openalex.org/W2559019668","https://openalex.org/W2737886613","https://openalex.org/W2528352583","https://openalex.org/W2980273054"],"abstract_inverted_index":{"423":[0],"Background:":[1],"HD":[2,55,126,223,241,277],"IL-2":[3,56,242,258,278,299],"has":[4],"been":[5],"reported":[6,262],"to":[7,32,110,149,155,164,199,257,280,298,319],"have":[8,119],"a":[9,19,54,67,101,165,210,272,284],"overall":[10],"response":[11],"rate":[12],"(ORR)":[13],"for":[14,172,215,276,294],"mRCC":[15,87],"of":[16,22,66,97,104,125,169,193,240,291],"15%":[17],"and":[18,40,73,100,135,145,188,328],"median":[20,102,158,166,196,226],"OS":[21,159,167,197,227,275],"19":[23],"months":[24,171,201,230,234],"(Fyfe,":[25],"1995),":[26],"however,":[27,308],"the":[28,85,225,264,289,337],"studies":[29],"that":[30,117],"led":[31],"its":[33],"regulatory":[34],"approval":[35],"are":[36,331],">15":[37],"years":[38],"old":[39],"were":[41,108,142,147,153,261],"performed":[42],"in":[43,183,202,213,263,336],"an":[44,76],"era":[45],"preceding":[46],"targeted":[47,174,292],"therapies.":[48],"Methods:":[49],"The":[50,129,157,237,268],"PROCLAIM":[51,214,269],"registry":[52,270],"(www.proclaimregistry.com),":[53],"observational":[57],"database":[58],"currently":[59,333],"with":[60,92,185,204,249,305],"over":[61],"30":[62],"participating":[63],"sites,":[64],"consists":[65],"retrospective":[68,86,265],"cohort":[69,79],"(treated":[70],"between":[71],"2007":[72],"2012)":[74],"informing":[75],"ongoing":[77],"prospective":[78,338],"(~600":[80],"patients).":[81],"We":[82],"report":[83],"on":[84],"subjects":[88],"(n=97,":[89],"13":[90],"sites)":[91],"survival":[93],"status":[94],"determined":[95],"as":[96,244,311,313],"November":[98],"2013":[99],"follow-up":[103],"32":[105],"months.":[106],"Sites":[107],"encouraged":[109],"enroll":[111],"patients":[112,118,184,203,217],"sequentially.":[113],"Inclusion":[114],"criteria":[115],"required":[116],"received":[120],"at":[121],"least":[122],"one":[123],"dose":[124],"IL-2.":[127],"Results:":[128],"ORR":[130],"was":[131,160,179,228],"22%":[132],"(8%":[133],"CR":[134],"14%":[136],"PR).":[137],"Of":[138],"97":[139],"subjects,":[140],"36":[141],"confirmed":[143],"deceased":[144],"61":[146],"known":[148],"be":[150],"alive,":[151],"none":[152,192],"lost":[154],"follow-up.":[156],"51":[161],"months,":[162],"compared":[163,198,279],"range":[168],"5-35":[170],"FDA-approved":[173],"agents":[175],"(Harrison,":[176],"2013).":[177,253],"There":[178,208],"significant":[180,211],"clinical":[181,238],"benefit":[182,239],"CR,":[186],"PR,":[187],"stable":[189,309],"disease":[190,206,310],"(SD),":[191],"which":[194],"reached":[195],"37.9":[200],"progressive":[205],"(PD).":[207],"is":[209,247,303],"advantage":[212],"those":[216],"treated":[218],"1st":[219],"vs.":[220,232],"2nd":[221],"line":[222,246,315],"IL-2;":[224],"61.8":[229],"(n=82)":[231],"15.3":[233],"(n=15),":[235],"respectively.":[236],"therapy":[243,293],"front":[245,314],"consistent":[248],"published":[250],"data":[251],"(Birkhauser,":[252],"No":[254],"deaths":[255],"due":[256],"related":[259],"toxicity":[260],"cohort.":[266],"Conclusions:":[267],"documents":[271],"vastly":[273],"improved":[274],"historical":[281],"results":[282],"during":[283],"time":[285],"interval":[286],"marked":[287],"by":[288],"advent":[290],"advanced":[295],"RCC.":[296],"Response":[297],"(CR":[300],"or":[301],"PR)":[302],"associated":[304],"prolonged":[306],"survival,":[307],"well":[312],"use":[316],"also":[317],"appears":[318],"positively":[320],"impact":[321],"survival.":[322],"Issues":[323],"including":[324],"patient":[325],"selection":[326],"characteristics":[327],"treatment":[329],"sequencing":[330],"hypotheses":[332],"being":[334],"explored":[335],"database.":[339],"Clinical":[340],"trial":[341],"information:":[342],"NCT01415167.":[343]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}